In-depth story on Vasalgel
The Medical Daily published a comprehensive news article on the development of male contraceptives, highlighting Vasalgel’s journey to market. Journalist Stephanie Castillo interviewed Parsemus Foundation’s
The Medical Daily published a comprehensive news article on the development of male contraceptives, highlighting Vasalgel’s journey to market. Journalist Stephanie Castillo interviewed Parsemus Foundation’s
Press release April 29, 2015 U.S. Northwest rescue organization presents first U.S. results in cats to win “Timmy Prize” for data collection on calcium chloride
We have a winner for the first “Timmy Prize” for data collection on the use of Calchlorin. A veterinarian and shelter in Northwest USA won
Evidence is mounting that hormone therapy (HT) after menopause is not associated with increased risks, despite earlier concerns. A recent meta-analysis of a number of
The topic of male contraception was covered in an article by Kristen Fawcett for US News and World Report. Vasalgel and Clean Sheets Pill were
Did you know that Parsemus Foundation maintains a list of veterinarians who offer ovary-sparing spay or other alternatives to traditional spay/neuter? Two new veterinary practices
Vasalgel has enjoyed significant media presence recently which is continuing into 2015. The Santa Fe Reporter highlighted the advancements that Vasalgel promises to bring to
Elaine Lissner, Director of Parsemus Foundation, was interviewed by ABC TV news – San Francisco. The piece focused on the development of Vasalgel and aired
Common birth control pills called combined oral contraceptives (COC) contain ethinyl-estradiol, a derivative of the estradiol found in the body. COCs are known to raise
Standard treatment for women who have had breast cancer is anti-estrogen therapy using aromatase inhibitors. But this treatment has serious implications for cardiovascular and bone
And if you don’t find a match there, this slightly more complex clinical trials finder includes studies sponsored by companies as well: